paroxysmal atrial fibrillation
Conditions
Interventions
control group:Conventional Western Medicine Treatment
treatment group:Conventional Western Medicine Treatment and Yi Xin Ding Ji Formula
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. It meets the diagnostic criteria of paroxysmal atrial fibrillation; 2.It meets the diagnostic criteria for traditional Chinese medicine Palpitations Heart yang deficiency pattern; 3.age =18 and =80 years old gender is not limited; 4.atrial fibrillation episodes frequency =2 times/month; 5.The subject has informed consent to participate in this study signed an informed consent form and is able to cooperate with treatment.
Exclusion criteria
Exclusion criteria: 1. Valvular heart disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, congenital heart disease with atrial fibrillation; 2. Atrial fibrillation triggered by reversible causes such as hyperthyroidism, electrolyte disorders, drugs, etc.; 3. Accompanied by sick sinus node syndrome or serious arrhythmia (high atrioventricular block, ventricular tachycardia, ventricular fibrillation, etc.); 4. Patients with cardiac pacemaking, coronary bypass grafting, and cardiac valves after heart valve surgery in the last 3 months; 5. Severe cardiac insufficiency (NYHA classification > ? or LVEF class III or LVEF < 40%); 6. Accompanied by coagulation disorders or bleeding tendency; 7. Combined systemic infections, malignant tumours, abnormalities of hepatic and renal function; 8. Suffering from severe psychiatric disorders or cognitive dysfunction; 9. Pregnant or lactating women or patients who plan to prepare for pregnancy in the near future; 10. Allergic, allergic to Multiple drug allergies; 11. Those who have received or are receiving traditional Chinese medicine treatment for 2 months; 12. Those who have participated or are participating in clinical trials of other drugs 1 month prior to enrolment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effective rate of treatment for paroxysmal atrial fibrillation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ferritin, transferrin;Traditional Chinese Medicine syndrome score and syndrome therapeutic effect;NT-proBNP and Growth stimulation expressed gene 2;homocysteine;EHRA points;blood fat;Recurrence rate of atrial fibrillation;Echocardiogram;24 hours dynamic electrocardiogram;Atrial Fibrillation Effect on Quality-of-Life;URIC ACID; | — |
Countries
China
Contacts
Public ContactShen Yan
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed